This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Council of Scientific and Industrial Research. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Inventor Atul Pathak: Pioneering Nucleic Acid Transfection Agents
Introduction: Atul Pathak, an innovative inventor based in Delhi, India, is making significant contributions to the field of biotechnology. With a focus on enhancing the delivery of biomolecules, his work aims to improve the efficiency of genetic transfection processes. His unique approaches in scientific research contribute to advancements in pharmaceuticals and medical treatments.
Latest Patents: Atul Pathak holds one notable patent titled "Crosslinked PEI nanoparticle transfection agents for delivery of biomolecules with increased efficiency." This invention introduces a novel crosslinked polyethylenimine (PEI) nanoparticle-based nucleic acid transfection agent. The innovation features a crosslinker with a carbon chain length ranging from C2 to C8, with a carbon content between 3.27-19.8%. The size of the nanoparticles falls between 20-600 nm, and they exhibit a zeta potential ranging from +5 to 50 mV, maximizing the efficiency of biomolecular delivery.
Career Highlights: Atul Pathak is associated with the Council of Scientific & Industrial Research, where he engages in pioneering research that bridges the gap between nanotechnology and molecular biology. His work emphasizes efficiency and effectiveness in delivering nucleic acids, which could lead to significant advancements in gene therapy and related fields.
Collaborations: Atul collaborates with esteemed colleagues such as Kailash Chand Gupta and Pradeep Kumar. Together, they contribute to successful research initiatives within the Council of Scientific & Industrial Research, pooling their expertise to drive innovation in the scientific community.
Conclusion: Atul Pathak exemplifies the role of an inventor dedicated to advancing technology in biotechnology through innovative solutions. His patent on crosslinked PEI nanoparticle transfection agents is a testament to his commitment to enhancing the efficiency of biomolecule delivery, promising potential benefits across various medical applications. With ongoing collaboration and research, Pathak is well-positioned to continue his impactful contributions to the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile